T-Cure BioScience, Inc.

T-Cure is a clinical-stage immuno-oncology company developing the next generation of T cell therapies for patients with solid tumors. It is committed to bringing new targets and therapies to the T-Cell Receptor (TCR) field that have a high likelihood of clinical efficacy. T-Cure is committed to delivering effective and durable cell therapies for the treatment of cancer. We are developing a new generation of clinical-stage T cell receptor (TCR) therapies to target and destroy solid tumors.